Amylin and bone metabolism in streptozotocin-induced diabetic rats

Journal of Bone and Mineral Research

Volumn 16, Issue 5, 2001, Pages 958-965

  Horcajada Molteni, Marie Noëlle ^a   Chanteranne, Brigitte ^a   Lebecque, Patrice ^a   Davicco, Marie Jeanne ^a   Coxam, Veronique ^a   Young, Andrew ^b   Barlet, Jean Pierre ^a  

^a CEMAGREF   (France)

^b AMY Pharmaceuticals   (United States)

Author keywords

Amylin; Diabetes; Osteopenia; Rat; Streptozotocin

Indexed keywords

AMYLIN; CALCIUM; CITRIC ACID; DEOXYPYRIDINOLINE; INSULIN; OSTEOCALCIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE BOWING; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; CALCIUM BONE LEVEL; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; RAT; TRABECULAR BONE;

AMYLOID; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EATING; HORMONE REPLACEMENT THERAPY; INSULIN; MALE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 0035059219     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.5.958     Document Type: Article

References (46)

1. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
2. AMY's physiology and its role in diabetes
3. Neuroendocrine actions of AMY
4. Multiple AMY receptors arise from receptor activity modifying protein interaction with the calcitonin receptor gene product
5. AMY receptor is revealed following cotransfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3
6. Preclinical pharmacology of pramlintide in the rat: Comparisons with rat and human AMY
7. AMYamide, bone conservation, and pancreatic β cells
8. AMY stimulates osteoblasts in vitro and in vivo
9. AMY in bone conservation: Current evidence and hypothetical considerations
10. AMY concentrations and glucose control
11. The effect of pramlintide (AMY analogue) treatment on bone metabolism and bone density in patients with type 1 diabetes mellitus
12. Effects of administration of pramlintide for 12 months on bone metabolism markers in people with type 1 diabetes
13. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: Study in vasopressin-deficient Brattelboro rats
14. Biochemical markers for assessing skeletal growth
15. Basic mechanical measurements of bone: A tutorial
16. Specific evaluation of localized bone mass and bone loss in the rat using dual energy X-ray absorptiometry subregional analysis
17. Factors influencing the assay of creatinine
18. Glucose determination with hexokinase and glucose-6-phosphate dehydrogenase
19. A prospective study of bone mass in patients with type 1 diabetes
20. Bone histomorphometric study in biopsied iliac bone in diabetic patients
21. Diabetic bone disease
22. Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy
23. Experimental diabetes, insulin treatment, and femoral neck morphology and biomechanics in rats
24. Circulating insulin levels are related to bone density in postmenopausal women
25. Insulin and bone: A clinical and scientific review
26. The characterization, regulation and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line
27. Insulin promotes growth of the cultured rat osteosarcoma cell line UMR-106-01: An osteoblast-like cell
28. Insulin increases the steady state level of alpha-1 procollagen mRNA in the osteoblast-rich fragment of fetal rat calvaria
29. Correction of altered collagen metabolism in diabetic animals with insulin therapy
30. Regulation of bone remodeling
31. Interaction of insulin-like growth factor I/somatomedin C with cultured rat chondrocytes: Receptor binding and internalization
32. Insulin receptor expression in primary and cultured osteoclast-like cells
33. Leptin and the regulation of body weight in mammals
34. La leptine: Une clé pour la reproduction
35. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
36. Human mesenchymal stem cells undergoing osteogenic differentiation express leptin and functional leptin receptor
37. Leptin inhibits osteoclast generation
38. Islet amyloid polypeptide (AMY) increases the renal excretion of calcium in the conscious dog
39. Effects of rat AMY on renal function in the rat
40. Distinct hemodynamic and renal effects of calcitonin gene-related peptide and calcitonin in men
41. AMY stimulates osteoblast proliferation and increases mineralized bone volume in adult mice
42. AMY increases bone volume but cannot ameliorate diabetic osteopenia
43. Systemic administration of AMY increases bone mass, linear growth, and adiposity in adult male mice
44. Dimensional analysis of osteoclastic bone resorption and the measurement of biologically active calcitonin
45. Comparison of the effects of calcitonin gene-related peptide and AMY on osteoblasts
46. The proliferative effects of AMY and adrenomedullin on osteoblasts - An important role for the IGF-1 receptor